Abstract
Exosomes are 60 to 90 nm membrane vesicles originating from late endosomes and secreted from most hematopoietic and epithelial cells in vitro. B cell derived-exosome antigenicity was first reported in 1996 in MHC class II restricted CD4+ T lymphocytes. In 1998, we reported that dendritic cell derived-exosomes are immunogenic in mice leading to tumor rejection. These findings have renewed the interest in exosomes. The current challenge consists in understanding the mechanisms and the physiological relevance of exosomes that could contribute to the design of the optimal exosome based-vaccination. Here, we will focus on the biological features pertaining to dendritic cell-and tumor cell derived-exosomes and will discuss their potential clinical implementation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Denzer, K., et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 2000; 113: 3365–74.
Denzer, K. et al. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 2000; 165: 1259–65.
Quah, B. and ONeill, H.C. The application of dendritic cell-derived exosomes in tumour immunotherapy. Cancer Biotherapy and Radiopharm 2000; 15: 185–194.
André, F. et al. Malignant effusions and immunogenic tumor derived-exosomes. The Lancet 2002; 360: 295–305.
Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998:4: 594–600.
Wolfers, J. et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001;7: 297–303.
Johnstone, R. M.et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem 1987; 262: 9412–9420.
Raposo, G. et al. Accumulation ofmajor histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Molec. Biol. Cell 1997; 8: 2631–2645.
Escola, J. M. et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. Journal of Biological Chemistry 1998;273;20121–7.
Arnold, P.Y. and Mannie, M.D. Vesicles bearing MHC class II molecules mediate transfer of antigen-presenting cells to CD4+ cells. Eur. J. Immunol 1999;29:1363–1373.
Heijnen, I. A. et al. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice, Journal of Clinical Investigation 1996; 97: 331–8.
Hess, C. et al. Ectosomes released by human neutrophils are specialized functional units. J Immunol 1999;163: 4564–73.
Patel, D. et al. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 1999;163: 5201–10.
Geminard, C. et al. Characteristics of the Interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation. J. Biol. Chem. 2001;276: 9910–9916.
Skokos, D. et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 2001;166: 868–76.
.Thery, C. et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999;147: 599–610.
Thery, C. et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166: 7309–18.
Clayton, A. et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods 2001;247: 163–74.
Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996;183: 11611172.
Blanchard, N. et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/z complex. J. Immunol 2002;168: 3235–3242.
Hanayama, R. et al. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002 May 9;417:182–7.
van Niel, G. et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001;121: 337–49.
Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J. & Sixma, J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94, 3791–9.
Lamparski H. et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods, 2002; 270: 211.
Pan, B.T. et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 1985;101: 942–948.
Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nature Review Immunol. 2002; 2: 569–579.
Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S. Exosomes activate naive CD4+ T cells by transfer of MHC/peptide complexes to dendritic cells. Nat. Immunol. In press.
Vincent-Schneider H., Stumptner-Cuvelette P., Lanka D., Pain S., Raposo G., Benaroch P., and Bonnerot C. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol. 2002; 14, 713–722.
Escudier B, Dorval T, Angevin E, Boccaccio C, Robert C, Avril MF, Lantz O, Bonnerot C, Tursz T, Dhellin O, Serra V, Valente N, Le-Pecq JB, Zitvogel L. Novel approach to immunotherapy of cancer: Phase I trial of dexosome vaccine for patients with advanced melanoma. Proc. Am. Soc. Clin. Oncol. 2002; A1857.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chaput, N., Schartz, N.E.C., Andre, F., Zitvogel, L. (2003). Exosomes for Immunotherapy of Cancer. In: Llombart-Bosch, A., Felipo, V. (eds) New Trends in Cancer for the 21st Century. Advances in Experimental Medicine and Biology, vol 532. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0081-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0081-0_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4914-3
Online ISBN: 978-1-4615-0081-0
eBook Packages: Springer Book Archive